Pure Hydrogen Corp Ltd (ASX: PH2) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Pure Hydrogen Corp Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$32.95 million
P/E Ratio
26.25
Dividend Yield
0.00%
Shares Outstanding
388.70 million
Earnings per share
-0.043
Dividend per share
N/A
Year To Date Return
-20.48%
Earnings Yield
3.81%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Pure Hydrogen Corp Ltd (ASX: PH2)
Latest News
Energy Shares
'The real struggle': Can an ASX investment in hydrogen really pay off?
Share Gainers
ASX hydrogen shares surge on 2023 federal budget $2b cash splash
Energy Shares
There were big winners and losers among ASX hydrogen shares in Q1. Here's the lowdown
Energy Shares
Are ASX hydrogen shares worth buying right now?
PH2 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Pure Hydrogen Corp Ltd
Pure Hydrogen Corp Ltd is engaged in the hydrogen business. The company is focused on developing hydrogen and gas projects. It operates in one segment, being energy development in Australia and Botswana.
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Thomas James Richard O'Brien | Non-Executive Director | Apr 2004 |
Mr O'Brien was Chief Executive Officer in Melbourne for the international accounting firm of Ernst and Young for 12 years and was also National Chairman of Ernst & Young Australia. He currently serves on boards including Ultrapay Limited, and Virtual Communities Limited. He is currently Chairman of Domaines Tatiarra Limited, Permo-Drive Technologies Limited and NewZeal Limited and was formerly Chairman of CCI Investments Management Limited and St Vincents and Mercy Private Hospital Limited and a member of the Board of Mercy Health and Aged Care.
|
| Mr Dennis Bastas | Chief Executive OfficerManaging Director | Dec 2003 |
Mr Bastas was the founding force behind the initial strategy and creation of Ascent. He has senior management experience in business development, retail services and supply chain management with companies including Coles Myer Limited, Mannesmann AG and Village Roadshow Limited.
|
| Mr Arun Kumar | Non-Executive Director |
Mr Kumar is the founder of Strides, which is listed on the Bombay Stock Exchange and the National Stock Exchange of India. He began his career in the exports department of Bombay Drug House Ltd., one of the exporters of pharmaceuticals from India and was soon promoted to head the International Division. In 1985, he started a consultancy firm - Strides Consultants - assisting companies in developing and implementing export strategies. He was instrumental in developing and opening up the export market for these companies. He has an experience and knowledge of the international pharmaceutical industry.
|
|
| Mr T S Rangan | Non-Executive Director |
Mr Rangan has over twenty years of experience in leading NYSE listed companies such as Xerox India, Astra Zeneca and Dr. Reddy's Laboratories Ltd. He has 8 carried out a research on Corporate Governance. He was a Government Nominee on the Central Council of the Institute of Cost and Works Accountants of India.
|
|
| Mr Andrew Burgess | Chief Financial OfficerCompany Secretary |
-
|
|
| Mr Michael Story | Senior Vice President | Jun 2007 |
-
|
| Stephen L. Blank | Company Secretary | Jul 2008 |
-
|
| Andrew Burgess | Chief Financial OfficerCompany Secretary |
-
|
|
| Stephen L. Blank | Company Secretary |
-
|
|
| A Heine | General Manager Sales and Marketing |
-
|
|
| Michael Story | Senior Vice President |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Linkace Limited | 150,489,600 | 60.33% |
| JP Morgan Nominees Australia Limited | 10,477,878 | 4.20% |
| I-Investments Pty Ltd | 8,010,352 | 3.21% |
| Mr Ravichandra Papanna | 6,527,000 | 2.62% |
| HSBC Custody Nominees (Australia) Limited-I | 3,596,792 | 1.44% |
| UBS Nominees Pty Ltd | 3,084,752 | 1.24% |
| PAN Australian Nominees Pty Limited | 3,000,000 | 1.20% |
| Perpetual Trustee Company Limited | 2,300,000 | 0.92% |
| Tynong Pastoral Co Pty Ltd | 2,243,667 | 0.90% |
| Brispot Nominees Pty Ltd | 2,220,938 | 0.89% |
| Mr Stuart James Hercules | 2,210,000 | 0.89% |
| Mandriola Investments Limited | 1,880,000 | 0.75% |
| Futura Investments Pte Ltd | 1,546,875 | 0.62% |
| Annamaki Pty Ltd The Belladonna Family Account | 1,494,533 | 0.60% |
| Genepharm Asia Pacific Enterprises Limited | 1,160,000 | 0.47% |
| Canamat Pty Ltd | 1,050,000 | 0.42% |
| HSBC Custody Nominees (Australia) Limited-II | 1,000,000 | 0.40% |
| Mr Leslie Gordon Ryan and Mrs Coral Valda Ryan | 1,000,000 | 0.40% |
| Knightsbrook Pty Ltd | 910,000 | 0.36% |
| Mr Alastair Galloway | 834,476 | 0.33% |
